Summary Comments
- Most frequently detected viruses across all age groups in November:
- Rhino/Enterovirus: 30.4%
- Rhinovirus: 25.2%
- SARS-CoV-2: 13.6%
- Parainfluenza virus 1–4: 9.1%
- Epidemiological Week 1–47:
- SARS-CoV-2: Decreased from 14.5% (week 43) to 11.2% (week 47)
- Influenza A: Low, 0.9% positivity (week 47)
- Influenza B: Increased from 5.8% (week 43) to 11.1% (week 46), slightly decreased to 8.8% (week 47)
Respiratory Viral Multiplex PCR and SARS-CoV-2 PCR: All Age Groups
October 2023:
- Rhino/Enterovirus: 27%
- Rhinovirus: 20.5%
- SARS-CoV-2: 7.6%
- Parainfluenza 1–4: 12.2%
- Adenovirus: 7.2%
- Influenza A: 3.7%
- Influenza B: 3.6%
- RSV: 1.9%
- Human metapneumovirus: 6.8%
November 2023:
- Rhino/Enterovirus: 30.4%
- Rhinovirus: 25.2%
- SARS-CoV-2: 13.3%
- Parainfluenza 1–4: 9.1%
- Adenovirus: 6.5%
- Influenza A: 0.9%
- Influenza B: 4.4%
- RSV: 1.2%
- Human metapneumovirus: 2.6%
Atypical Bacterial Pathogens (Weeks 1–47)
Cases Detected:
- B. pertussis: 566 cases
- 0–6 months: 25%
- 6–12 years: 23%
- 1–5 years: 19% 18 years: 23%
- M. pneumoniae: 1,621 cases
- Peak: week 25 (72 cases)
- 1–5 years: 37%
- 6–12 years: 28%
Weekly case progression visualized in chart format
Paediatric Respiratory Viral Multiplex PCR Data (Ages 0–12)
<1 Year Age Group
October 2023:
- Rhino/Enterovirus: 35.8%
- Rhinovirus: 28.7%
- Parainfluenza 1–4: 13.6%
- Adenovirus: 9.3%
- SARS-CoV-2: 11.3%
- RSV: 5.2%
- Influenza A: 4.2%
- Influenza B: 0.4%
- Enterovirus: 4.3%
November 2023:
- Rhino/Enterovirus: 45%
- Rhinovirus: 29%
- Parainfluenza 1–4: 13.6%
- Adenovirus: 9.3%
- SARS-CoV-2: 9.3%
- RSV: 3.4%
- Influenza A: 3.1%
- Influenza B: 3.4%
- Enterovirus: 4%
1–5 Year Age Group
October 2023:
- Rhino/Enterovirus: 47.3%
- Rhinovirus: 32.7%
- Enterovirus: 17.3%
- Adenovirus: 5.5%
- SARS-CoV-2: 14.8%
- Influenza A: 7.2%
- Influenza B: 4.5%
- RSV: 3.6%
November 2023:
- Rhino/Enterovirus: 52%
- Rhinovirus: 40%
- Enterovirus: 17.3%
- Adenovirus: 10.9%
- SARS-CoV-2: 14.5%
- Influenza A: 6.3%
- Influenza B: 3.8%
- RSV: 2.4%
6–12 Year Age Group
October 2023:
- Rhino/Enterovirus: 33.9%
- Rhinovirus: 34.9%
- Influenza B: 10.5%
- SARS-CoV-2: 6.4%
- Influenza A: 1%
- Adenovirus: 2.9%
- RSV: 0.4%
November 2023:
- Rhino/Enterovirus: 33.9%
- Rhinovirus: 34.9%
- Influenza B: 18.2%
- SARS-CoV-2: 6.1%
- Influenza A: 0.9%
- Adenovirus: 2.8%
- RSV: 0.4%
Age-Specific Highlights (November 2023)
- <1 year:
- Rhino/Enterovirus (45%), Rhinovirus (29%), Parainfluenza 1–4 (13.6%), Adenovirus (9.3%)
- 1–5 years:
- Rhino/Enterovirus (52%), Rhinovirus (40%), Enterovirus (17.3%)
- 6–12 years:
- Rhinovirus (34.9%), Rhino/Enterovirus (33.9%), Influenza B (18.2%)
Continue Reading